Campbell & CO Investment Adviser LLC - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 362 filers reported holding NOVOCURE LTD in Q2 2021. The put-call ratio across all filers is 0.83 and the average weighting 0.2%.

Quarter-by-quarter ownership
Campbell & CO Investment Adviser LLC ownership history of NOVOCURE LTD
ValueSharesWeighting
Q3 2023$749,618
+251.9%
46,416
+1413.9%
0.09%
+57.9%
Q2 2022$213,000
-60.6%
3,066
-57.4%
0.06%
-69.2%
Q4 2021$541,000
+87.8%
7,200
+453.8%
0.18%
+55.5%
Q2 2021$288,000
+20.0%
1,300
-54.4%
0.12%
+60.8%
Q4 2019$240,000
-0.4%
2,848
-25.2%
0.07%
-32.1%
Q2 2019$241,0000.0%3,805
-50.6%
0.11%
-41.1%
Q2 2018$241,0007,7000.18%
Other shareholders
NOVOCURE LTD shareholders Q2 2021
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 350,884$26,344,0008.01%
HARTLINE INVESTMENT CORP/ 318,109$23,884,0003.27%
Deep Track Capital, LP 550,000$41,294,0002.92%
MORGAN JESS S & CO INC 43,975$3,302,0002.03%
Taylor Frigon Capital Management LLC 46,376$3,482,0001.09%
Darsana Capital Partners LP 258,937$19,441,0000.90%
Private Harbour Investment Management & Counsel, LLC 13,562$1,018,0000.81%
Rhenman & Partners Asset Management AB 120,387$9,610,0000.64%
COURAGE CAPITAL MANAGEMENT LLC 10,000$751,0000.50%
Baillie Gifford 9,615,168$721,906,0000.40%
View complete list of NOVOCURE LTD shareholders